Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Sanders

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
British Journal of Clinical Pharmacology|December 5, 2015
Mean steady-state plasma concentrations of labetalol in patients undergoing antihypertensive therapyG L Sanders, P A Routledge, A Ward, et al.
British Journal of Clinical Pharmacology|December 5, 2015
A comparative study of methyldopa and labetalol in the treatment of hypertensionG L Sanders, D M Davies, G M Gales, et al.
British Journal of Clinical Pharmacology|December 5, 2015
A multicentre open trial of labetalol in New ZealandG L Sanders, D M Davies, G M Gales, et al.
European Journal of Clinical Pharmacology|December 18, 1978
Labetalol, a cross-over double blind controlled trialG L Sanders, P A Routledge, J G Rao, et al.
British Journal of Clinical Pharmacology|January 1, 1979
A comparative study of methyldopa and labetalol in the treatment of hypertensionG L Sanders, D M Davies, G M Gales, et al.
The Journal of Clinical Investigation|October 1, 1972
The Anrep effect reconsideredR G Monroe, W J Gamble, C G LaFarge, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
British Journal of Clinical Pharmacology|December 5, 2015
Mean steady-state plasma concentrations of labetalol in patients undergoing antihypertensive therapyG L Sanders, P A Routledge, A Ward, et al.
British Journal of Clinical Pharmacology|December 5, 2015
A comparative study of methyldopa and labetalol in the treatment of hypertensionG L Sanders, D M Davies, G M Gales, et al.
British Journal of Clinical Pharmacology|December 5, 2015
A multicentre open trial of labetalol in New ZealandG L Sanders, D M Davies, G M Gales, et al.
European Journal of Clinical Pharmacology|December 18, 1978
Labetalol, a cross-over double blind controlled trialG L Sanders, P A Routledge, J G Rao, et al.
British Journal of Clinical Pharmacology|January 1, 1979
A comparative study of methyldopa and labetalol in the treatment of hypertensionG L Sanders, D M Davies, G M Gales, et al.
The Journal of Clinical Investigation|October 1, 1972
The Anrep effect reconsideredR G Monroe, W J Gamble, C G LaFarge, et al.
Pageof 2